Susquehanna Starts Salix Pharma (SLXP) at Positive, Sets $50 Target
Tweet
Share
E-mailGet Alerts SLXP Hot Sheet
Price: $172.81 --0%
Rating Summary:
7 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 20 | New: 18
Rating Summary:
7 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 20 | New: 18
Join SI Premium – FREE
An analyst at Susquehanna initiated coverage on shares of Salix Pharmaceuticals (NASDAQ: SLXP) with a Positive rating and a $50 price target this morning.
With SLXP shares down 1.8 percent to $37.99 Friday afternoon, the firm's new price target suggests potential price appreciation of about 32 percent.
For more ratings news on Salix Pharmaceuticals click here and for the rating history of Salix Pharmaceuticals click here.
With SLXP shares down 1.8 percent to $37.99 Friday afternoon, the firm's new price target suggests potential price appreciation of about 32 percent.
For more ratings news on Salix Pharmaceuticals click here and for the rating history of Salix Pharmaceuticals click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts Interactive Brokers Group (IBKR) at Market Perform
- Raymond James Starts Kearny Financial (KRNY) at Outperform
- KeyBanc Starts Vivmark Residential (VMRK) at Sector Weight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Susquehanna International Group of CompaniesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
